{"id":"bnt111","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, swelling at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BNT111 is a mRNA-based vaccine that encodes for the SARS-CoV-2 spike protein, eliciting an immune response to protect against COVID-19. The vaccine uses a lipid nanoparticle to deliver the mRNA to cells, where it is translated into the spike protein and presented to the immune system. This triggers an immune response, providing protection against the virus.","oneSentence":"BNT111 is a COVID-19 vaccine candidate.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:20:00.751Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention"}]},"trialDetails":[{"nctId":"NCT02410733","phase":"PHASE1","title":"Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2015-03","conditions":"Melanoma","enrollment":119},{"nctId":"NCT04526899","phase":"PHASE2","title":"A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2021-05-19","conditions":"Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma","enrollment":184}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BNT111","genericName":"BNT111","companyName":"BioNTech SE","companyId":"biontech-se","modality":"Biologic","firstApprovalDate":"","aiSummary":"BNT111 is a COVID-19 vaccine candidate. Used for COVID-19 prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}